Nebenwirkungen · Vipidia
Vipidia 6.25 mg film-coated tablets Vipidia 12.5 mg film-coated tablets Vipidia 25 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 7
HOS-124732 · Präparat HOS-095921
System organ class Frequency of adverse reactions Adverse reaction Infections and infestations upper respiratory tract infections common nasopharyngitis common Immune system disorders hypersensitivity not known Metabolism and nutrition disorders hypoglycaemia common Nervous system disorders headache common Gastrointestinal disorders abdominal pain common gastroesophageal reflux disease common diarrhoea common acute pancreatitis not known Hepatobiliary disorders hepatic dysfunction including hepatic failure not known Skin and subcutaneous tissue disorders pruritus common rash common exfoliative skin conditions including Stevens-Johnson syndrome not known erythema multiforme not known angioedema not known urticaria not known bullous pemphigoid not known Renal and urinary disorders interstitial nephritis not known
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2023-07-21T15:44:00Z · SHA-256 a158be115f1731a24f22d5889497861461a6d2e7b0b88793feebe88b5bedab3b · Passage cd17af29f0e8818f5d64a05f95280c48f1a5412cd70f3f4bda3b9f259b56e1f6 · Zeichen 1989–3905 im Abschnitt